In all fairness narmac , bkc acknowledged its old but the difference being is this is an "example of recognition of Apabetalone trial results by an article in a journal with a high impact factor"

& as bkc said we didn't have to beg or pay to get it done, it was independently done.

unfortunetly it has not had a high impact on our SP but where it may be of greater importance is BP now recognizing it even more & maybe gives dm & group another tick in their negotiations.Hopefulky the market just don't get it & we surprise all. Confidence is low but just maybe ....,